Clenbuterol on Motor Function in Individuals With Amyotrophic Lateral Sclerosis
Status:
Completed
Trial end date:
2021-03-10
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and tolerability of clenbuterol (taken by
mouth) in subjects with ALS (amyotrophic lateral sclerosis) and to assess the effectiveness
of clenbuterol with regard to motor function in subjects with ALS. Subjects will be in this
study approximately 24 weeks. The study drug, clenbuterol, is taken twice a day. As part of
this study subjects will have the following tests and procedures: medical history, vital
signs, physical examination, blood tests, heart and lung function tests, muscle function
test, ALSFRS-R (ALS Functional Rating Scale Revised), thyroid function and for women who can
become pregnant, pregnancy tests.